Evidence-based treatment guidelines for OA inform clinicians about proper management of this common chronic condition, but studies show those recommendations aren’t being implemented effectively in real-world clinical settings. READ MORE

Social media use — and misuse — continues to increase, so a Monday morning session at the ACR/ARP Annual Meeting focused on how medical professionals can successfully navigate the digital world. READ MORE

There is growing recognition that key events in autoimmune disease onset and amplification occur in lymphoid and target tissues affected by the disease process, and a Tuesday morning session will feature state of-the-art data on novel investigative approaches. READ MORE

Electronic documentation was designed to streamline practices and save clinicians time and money. If the system used in your practice isn’t, then Tuesday’s Business Administration session How to Make the EMR Work for You may be able to provide some practical tips and tricks. READ MORE

According to data published in Arthritis & Rheumatology, and a recent ACR workforce analysis highlighting a lack of rheumatology care in rural areas, the need for telehealth access may be greater than ever. READ MORE

APR Distinguished Lecturer Charles G. Helmick III, MD, provided a look a public health and why it’s important — and why arthritis and other rheumatologic conditions are public health issues. READ MORE

Three scleroderma experts will outline approaches to scleroderma skin involvement, interstitial lung disease, and pulmonary hypertension during the Wednesday Clinical Practice session, Scleroderma Treatment 2019. READ MORE

The registry is a rich, best-in-class resource developed by the American College of Rheumatology, and is the first and largest national EHR-enabled rheumatology registry in the United States. READ MORE

New findings open up the potential for new therapies for autoimmune and inflammatory diseases, such as RA, that target these new functions of complement. READ MORE

Tuesday will see the ACR’s first-ever session on histiocytic disorders, which have traditionally been seen as rare, obscure, and without good treatment options. READ MORE